Drugs & therapies
Drugs & therapies coverage from Benchtobed.
GLP-1s: semaglutide, tirzepatide, retatrutide in trialsAlzheimer's: lecanemab, donanemab, anti-amyloid classOncology: pembrolizumab, nivolumab, antibody drug conjugates, CAR-TGene and cell therapy: exagamglogene autotemcel, lovotibeglogene, onasVaccines: mRNA platforms, RSV vaccines, next generation COVID vaccinesCardiometabolic: inclisiran, bempedoic acid, SGLT2 inhibitorsBiosimilars and generics entering the marketDrugs withdrawn or restricted after approval
No articles filed here yet. New reporting appears as it is published.